The effects of intravenous anesthetics on mouse embryonic fibroblast viability and proliferation

J Anesth. 2012 Oct;26(5):675-81. doi: 10.1007/s00540-012-1427-1. Epub 2012 Jun 20.

Abstract

Purpose: The aim of this study is to evaluate the cytotoxic and antiproliferating effects of intravenous anesthetics on an mouse fibroblast in vitro cell culture system.

Methods: The cells were exposed to the usual clinical plasma concentration of intravenous anesthetics, i.e., midazolam (0.15 μg/ml), propofol (2 μg/ml), remifentanil (2 μg/ml), thiopental (10 μg/ml), for 4, 8, or 24 h. Cell proliferation (n = 6 for each) under intravenous anesthetics was analyzed using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. Cytotoxicity (n = 6 for each) of intravenous anesthetics was investigated using a LIVE/DEAD viability assay kit.

Results: Intravenous anesthetic exposure time did not affect the proliferation rate of mouse fibroblasts. The cytotoxicity of intravenous anesthetics did not differ in accordance with exposure time.

Conclusion: Our results showed that intravenous anesthetics may not affect mouse fibroblast proliferation and viability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthetics, Intravenous / pharmacology*
  • Anesthetics, Intravenous / toxicity*
  • Animals
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Cells, Cultured
  • Embryo, Mammalian / cytology
  • Embryo, Mammalian / drug effects
  • Fibroblasts / drug effects*
  • Mice
  • Midazolam / adverse effects
  • Midazolam / pharmacology
  • Piperidines / adverse effects
  • Piperidines / pharmacology
  • Propofol / adverse effects
  • Propofol / pharmacology
  • Remifentanil
  • Thiopental / adverse effects
  • Thiopental / pharmacology

Substances

  • Anesthetics, Intravenous
  • Piperidines
  • Thiopental
  • Remifentanil
  • Midazolam
  • Propofol